JP2004516300A5 - - Google Patents

Download PDF

Info

Publication number
JP2004516300A5
JP2004516300A5 JP2002551992A JP2002551992A JP2004516300A5 JP 2004516300 A5 JP2004516300 A5 JP 2004516300A5 JP 2002551992 A JP2002551992 A JP 2002551992A JP 2002551992 A JP2002551992 A JP 2002551992A JP 2004516300 A5 JP2004516300 A5 JP 2004516300A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002551992A
Other versions
JP2004516300A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2001/014163 external-priority patent/WO2002050099A2/en
Publication of JP2004516300A publication Critical patent/JP2004516300A/ja
Publication of JP2004516300A5 publication Critical patent/JP2004516300A5/ja
Pending legal-status Critical Current

Links

JP2002551992A 2000-11-27 2001-11-27 化学的に合成したポリペプチドをフォールディングする方法 Pending JP2004516300A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00204207 2000-11-27
PCT/EP2001/014163 WO2002050099A2 (en) 2000-11-27 2001-11-27 Process for folding chemically synthesized polypeptides

Publications (2)

Publication Number Publication Date
JP2004516300A JP2004516300A (ja) 2004-06-03
JP2004516300A5 true JP2004516300A5 (ja) 2005-08-18

Family

ID=8172340

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002551992A Pending JP2004516300A (ja) 2000-11-27 2001-11-27 化学的に合成したポリペプチドをフォールディングする方法

Country Status (22)

Country Link
US (2) US20020082384A1 (ja)
EP (2) EP1337549B1 (ja)
JP (1) JP2004516300A (ja)
KR (1) KR20030081315A (ja)
CN (2) CN1249078C (ja)
AT (1) ATE322501T1 (ja)
AU (2) AU2960302A (ja)
BR (1) BR0113091A (ja)
CA (1) CA2416054A1 (ja)
CU (1) CU23034A3 (ja)
DE (1) DE60118598T2 (ja)
DK (1) DK1337549T3 (ja)
ES (1) ES2261509T4 (ja)
HU (1) HUP0302395A3 (ja)
IL (1) IL155506A0 (ja)
MX (1) MXPA03003576A (ja)
NO (1) NO20032356D0 (ja)
NZ (1) NZ523679A (ja)
PL (1) PL364932A1 (ja)
RU (1) RU2275377C2 (ja)
WO (1) WO2002050099A2 (ja)
ZA (1) ZA200300642B (ja)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7091310B2 (en) * 2002-09-13 2006-08-15 Chemokine Therapeutics Corporation Chemokine analogs for the treatment of human disease
US7214660B2 (en) 2001-10-10 2007-05-08 Neose Technologies, Inc. Erythropoietin: remodeling and glycoconjugation of erythropoietin
US7173003B2 (en) 2001-10-10 2007-02-06 Neose Technologies, Inc. Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
WO2004099231A2 (en) 2003-04-09 2004-11-18 Neose Technologies, Inc. Glycopegylation methods and proteins/peptides produced by the methods
WO2005012484A2 (en) 2003-07-25 2005-02-10 Neose Technologies, Inc. Antibody-toxin conjugates
US20080305992A1 (en) 2003-11-24 2008-12-11 Neose Technologies, Inc. Glycopegylated erythropoietin
KR20070083815A (ko) * 2004-10-26 2007-08-24 론자 아게 고체상 합성에서 s-알킬-술페닐 보호기
EP1814573B1 (en) 2004-10-29 2016-03-09 ratiopharm GmbH Remodeling and glycopegylation of fibroblast growth factor (fgf)
ES2449195T3 (es) 2005-01-10 2014-03-18 Ratiopharm Gmbh Factor estimulante de colonias de granulocitos glicopegilado
EP1871795A4 (en) 2005-04-08 2010-03-31 Biogenerix Ag COMPOSITIONS AND METHOD FOR PRODUCING GLYCOSYLATION MUTANTS OF A PROTEASE-RESISTANT HUMAN GROWTH HORMONE
ES2553160T3 (es) * 2005-06-17 2015-12-04 Novo Nordisk Health Care Ag Reducción y derivatización selectivas de proteínas Factor VII transformadas por ingeniería que comprenden al menos una cisteína no nativa
US20070105755A1 (en) 2005-10-26 2007-05-10 Neose Technologies, Inc. One pot desialylation and glycopegylation of therapeutic peptides
US20090048440A1 (en) 2005-11-03 2009-02-19 Neose Technologies, Inc. Nucleotide Sugar Purification Using Membranes
US20090081145A1 (en) * 2005-12-23 2009-03-26 Aplagen Gmbh Process for forming disulphide bridges
AU2007248855A1 (en) * 2006-05-03 2007-11-15 Mallinckrodt Inc. Composition and method for the release of protected peptides from a resin
CN101516388B (zh) 2006-07-21 2012-10-31 诺和诺德公司 通过o-联糖基化序列的肽的糖基化
WO2008057683A2 (en) 2006-10-03 2008-05-15 Novo Nordisk A/S Methods for the purification of polypeptide conjugates
EP2125863A1 (de) * 2006-12-23 2009-12-02 AplaGen GmbH Verfahren zur ausbildung von disulfidbrücken
KR20100016160A (ko) 2007-04-03 2010-02-12 바이오제너릭스 에이지 글리코페길화 g―csf를 이용하는 치료 방법
WO2008154639A2 (en) 2007-06-12 2008-12-18 Neose Technologies, Inc. Improved process for the production of nucleotide sugars
ES2476690T3 (es) 2008-02-27 2014-07-15 Novo Nordisk A/S Moléculas conjugadas del Factor VIII
CN104844693B (zh) * 2015-06-10 2018-08-03 成都圣诺生物科技股份有限公司 一种合成利那洛肽的方法
WO2019149918A1 (en) 2018-02-02 2019-08-08 Novo Nordisk A/S Drug injection device with deflectable transducer
CN111100188A (zh) * 2018-10-25 2020-05-05 成都医学院 一种制备蜘蛛抗菌肽的方法
CN109593119A (zh) * 2019-01-27 2019-04-09 上海丽珠制药有限公司 一种[2-d-组氨酸]-醋酸亮丙瑞林的制备方法
JP7453745B2 (ja) * 2019-03-28 2024-03-21 株式会社ヤクルト本社 毒性タンパク質の活性を阻害するペプチドのスクリーニング方法及び毒性タンパク質の製造方法
CN110845595A (zh) * 2019-11-14 2020-02-28 连云港职业技术学院 一种固相合成5-tmara标记的铁调素-25的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2923787A1 (de) * 1979-06-12 1980-12-18 Max Planck Gesellschaft Verfahren zur selektiven bildung von disulfidbruecken in polypeptiden und die dabei erhaltenen produkte als wirkstoffe enthaltende arzneimittel
DE3236849A1 (de) * 1982-10-05 1984-04-05 Max Planck Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Neue thiohydrazin-1,2-dicarbonsaeure-derivate, verfahren zu ihrer herstellung und ihre verwendung
IL96682A0 (en) * 1989-12-15 1991-09-16 Amgen Inc Production of biologically active platelet-derived growth factor from high expression host cell systems
CA2072249C (en) * 1991-06-28 2003-06-17 Saiko Hosokawa Human monoclonal antibody specifically binding to surface antigen of cancer cell membrane
EP0628573A1 (en) * 1993-05-24 1994-12-14 Kao Corporation Process for producing solubilized protein
US5663304A (en) * 1993-08-20 1997-09-02 Genentech, Inc. Refolding of misfolded insulin-like growth factor-I
DE4431317A1 (de) * 1994-09-02 1996-03-07 Biotechnolog Forschung Gmbh Schutz- bzw. Ankergruppen und deren Verwendung

Similar Documents

Publication Publication Date Title
BE2022C531I2 (ja)
BE2022C502I2 (ja)
BE2022C547I2 (ja)
BE2017C056I2 (ja)
BE2017C051I2 (ja)
BE2016C051I2 (ja)
BE2015C046I2 (ja)
BE2014C052I2 (ja)
BE2014C036I2 (ja)
BE2014C026I2 (ja)
BE2014C004I2 (ja)
BE2014C006I2 (ja)
BE2017C050I2 (ja)
BE2011C034I2 (ja)
BE2007C047I2 (ja)
AU2002307149A8 (ja)
BRPI0209186B1 (ja)
CH1379220H1 (ja)
BRPI0204884B1 (ja)
BE2016C021I2 (ja)
BE2017C059I2 (ja)
BE2012C051I2 (ja)
BRPI0210463A2 (ja)
HU0202201D0 (ja)
BRMU8103221U (ja)